Key Product Details

Species Reactivity

Validated:

Virus

Applications

ELISA, Lateral Flow Assay

Label

Janelia Fluor 549

Antibody Source

Monoclonal Mouse IgG2B Clone # 9C5cc

Concentration

Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.

View all Respiratory Syncytial Virus Antibodies »

Product Summary for Respiratory Syncytial Virus Antibody (9C5cc) [Janelia Fluor® 549]

Immunogen

Hybridoma clone has been derived from hybridization of Sp2/0 myeloma cells with spleen cells of Balb/c mice immunized with purified RSV, strain Long.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2B

Applications for Respiratory Syncytial Virus Antibody (9C5cc) [Janelia Fluor® 549]

Application
Recommended Usage

ELISA

Optimal dilutions of this antibody should be experimentally determined.

Lateral Flow Assay

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Protein A purified

Formulation

50mM Sodium Borate

Preservative

0.05% Sodium Azide

Concentration

Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: Respiratory Syncytial Virus

RSV (Respiratory Syncytial Virus) is a negative sense RNA paramyxovirus in which the major virus neutralization antigens are the glycoprotein (G) and the fusion (F) protein that mediate attachment and fusion to the host cell during virus infection, respectively. Other RSV proteins include the nucleocapsid protein (N) and the M2 protein. The two major subgroups of RSV are A and B with the A strain being more virulent and responsible for the majority of severe RSV infections. Respiratory syncytial virus infection is responsible for a large proportion of viral respiratory infections, and significant morbidity is associated with RSV infections. To date, few RSV vaccine candidates have shown promise with no human vaccine yet been proven safe and efficacious.

Alternate Names

Fusion glycoprotein F0, Fusion glycoprotein F1, Fusion glycoprotein F2, RS virus, RSV

Additional Respiratory Syncytial Virus Products

Product Documents for Respiratory Syncytial Virus Antibody (9C5cc) [Janelia Fluor® 549]

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Download SDS

Product Specific Notices for Respiratory Syncytial Virus Antibody (9C5cc) [Janelia Fluor® 549]



Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.